Former FDA Commissioner Hahn Faces Questions From House On Trump Interference, Other COVID Issues

The request for an interview by the House Select Subcommittee on the Coronavirus Crisis seeks more information on the actions by President Trump and others to influence FDA decisions on HCQ, convalescent plasma, and vaccine decisions.

Stephen Hahn (left) and Donald Trump at March 30, 2020 COVID-19 White House briefing.
Stephen Hahn, left, at the time FDA Commissioner, and then-President Trump speak during a White House coronavirus briefing on 30 March 2020. • Source: Alamy

Former US Food and Drug Administration Commissioner Stephen Hahn could face uncomfortable questions from congressional investigators about the decisions he and others at the agency and the White House made to respond to the COVID-19 pandemic.

Hahn has been asked to sit for a transcribed interview with the House Select Subcommittee on the Coronavirus Crisis, which...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Agency Leadership